A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic Chemotherapy
Clinical trial NCT02400866 · UNKNOWN
Trial details
- NCT number
- NCT02400866
- Sponsor
- Korean South West Oncology Group
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2015-11-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.